Search for: "MATTER OF G P" Results 281 - 300 of 1,852
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jul 2021, 11:59 am by Kristi Wolff and Jaclyn Metzinger
  Accordingly, the court found that it was competent to resolve the matter without waiting for the FDA to weigh in. [read post]
12 Apr 2016, 3:43 am by Broc Romanek
By popular demand, this comprehensive “Non-GAAP Financial Measures Handbook” covers a challenging topic, from the basics to everything you want to know about Regulation G, Item 10(e) of Regulation S-K & Form 8-K’s Item 2.02. [read post]
11 Sep 2009, 1:28 am
You should use this citation whenever you cite the opinion, with a P.3d parallel citation. [read post]
12 Apr 2016, 3:43 am by Broc Romanek
By popular demand, this comprehensive “Non-GAAP Financial Measures Handbook” covers a challenging topic, from the basics to everything you want to know about Regulation G, Item 10(e) of Regulation S-K & Form 8-K’s Item 2.02. [read post]
3 Mar 2009, 5:38 am
You should use this citation whenever you cite the opinion, with a P.3d parallel citation. [read post]
25 Sep 2016, 9:01 pm by Neil Cahn
 was quickly followed by the decision of the Appellate Division, Second Department in Matter of Frank G. v Renee P. [read post]
25 Sep 2016, 9:01 pm by Neil Cahn
 was quickly followed by the decision of the Appellate Division, Second Department in Matter of Frank G. v Renee P. [read post]
3 Mar 2013, 5:01 pm by oliver randl
The methods differ essentially in that in the method according to claim 1, (i) the linear matrix equation ‘p = G x w’ used in document D6 to represent the linear effect of the concentration estimates – where p is a column vector which describes the peak quantitation data of a DNA sample from the signal, G is a matrix that represents the genotypes in the DNA sample and w is a weight column vector that represents relative proportions of template… [read post]
28 Apr 2010, 3:19 pm by Robert J. McKennon
Based on those findings, the district court remanded the matter to Reliance for reconsideration, ordering it to make a new benefits determination, after which it finally granted the benefits due. [read post]
12 May 2009, 3:32 am
Martin of Patton Boggs LLP, Washington, DC; Scott P. [read post]
24 Jan 2014, 7:10 am by Jackie Hutter, IP Strategist
Before someone gets hung up on making sure that they are obtaining a suitably “strategic” patent, a good thing to remember is that patents rarely matter, but when they matter, they matter a lot. [read post]
24 Jan 2014, 7:10 am by Jackie Hutter, IP Strategist
Before someone gets hung up on making sure that they are obtaining a suitably “strategic” patent, a good thing to remember is that patents rarely matter, but when they matter, they matter a lot. [read post]
” She thus concludes that “[p]laintiff has an interest in and need for at least a portion of it. [read post]